Mutations in the spliceosome genes U2AF1 and SF3B1 have been linked to the expression of oncogenic IRAK4 isoforms in myeloid malignancies [18,29,30], and may impose sensitivity to IRAK4 inhibition [31]. Here, IRAK4 is linked to myeloid neoplasm.